{"schema_version":"secwatch.filing_event.v1","accession":"0000856982-24-000035","form_type":"8-K","ticker":"MMSI","cik":"0000856982","company_name":"MERIT MEDICAL SYSTEMS INC","filed_at":"2024-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.152224+00:00","generated_at":"2026-06-03T05:10:19.605903+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Merit Medical Q1 2024 revenue $323.5M (+8.7% YoY); GAAP EPS $0.48 (+35.5%)","bullets":["Revenue $323.5M, up 8.7% YoY; constant currency revenue up 9.3%; organic constant currency up 7.0%.","GAAP operating margin 11.1% vs 8.9% in Q1 2023; non-GAAP operating margin 17.3% vs 16.1%.","GAAP EPS $0.48, up 35.5% from $0.36; non-GAAP EPS $0.77, up 18.7% from $0.64.","Non-GAAP measures include constant currency and organic growth; reconciliations in press release.","No specific guidance update provided; Q1 results discussed on April 30 conference call."],"urls":{"canonical":"https://secwatch.observer/filing/0000856982-24-000035","json":"https://secwatch.observer/filing/0000856982-24-000035.json","markdown":"https://secwatch.observer/filing/0000856982-24-000035.md","text":"https://secwatch.observer/filing/0000856982-24-000035.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/856982/000085698224000035/0000856982-24-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/856982/000085698224000035/mmsi-20240430x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T05:10:19.605903+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"503c8c61c49a553165aab0d7870367da47a4ad34","claim":"MERIT MEDICAL SYSTEMS INC reported first quarter ended March 31, 2024 results: revenue $323.5 million, EPS $0.48.","evidence_excerpt":"mike.piccinino@westwicke.com ​ ​ ​ ​ ​ ​ ​ ​ FOR IMMEDIATE RELEASE MERIT MEDICAL REPORTS RESULTS FOR FIRST QUARTER ENDED MARCH 31, 2024 ● Q1 2024 reported revenue of $323.5 million, up 8.7% compared to Q1 2023 ● Q1 2024 constant currency revenue* up 9.3% compared to Q1 2023 ● Q1 2024 constant currency revenue, organic* up 7.0% compared to Q1 2023 ● Q1 2024","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/856982/000085698224000035/0000856982-24-000035-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Revenue","value":"$323.5 million"},{"label":"EPS","value":"$0.48"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}